24
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Differential efficacy of gonadotropin-releasing hormone (GnRH) agonist treatment on pedunculated and degenerated myomas: a retrospective study of 630 women

Pages 504-506 | Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ming-Huei Cheng & Peng-Hui Wang. (2008) Uterine myoma: a condition amendable to medical therapy?. Expert Opinion on Emerging Drugs 13:1, pages 119-133.
Read now

Articles from other publishers (3)

Marissa Frijlingh, Inge De Milliano, Wouter. J.K. Hehenkamp & Judith. A.F. Huirne. (2020) Differences in fibroid vascularity after three months of pre-treatment with leuprolide acetate or ulipristal acetate: A pilot study. European Journal of Obstetrics & Gynecology and Reproductive Biology 245, pages 186-192.
Crossref
Shigeo Okuda, Koichi Oshio, Hiroshi Shinmoto, Akihiro Tanimoto, Hironori Asada, Takuma Fujii, Yasunori Yoshimura & Sachio Kuribayashi. (2008) Semiquantitative Assessment of MR Imaging in Prediction of Efficacy of Gonadotropin-releasing Hormone Agonist for Volume Reduction of Uterine Leiomyoma: Initial Experience. Radiology 248:3, pages 917-924.
Crossref
Ming-Hui Cheng, Hsiang-Tai Chao & Peng-Hui Wang. (2008) Medical Treatment for Uterine Myomas. Taiwanese Journal of Obstetrics and Gynecology 47:1, pages 18-23.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.